Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artemisinins.

C J Woodrow1, R K Haynes, S Krishna

  • 1Department of Cellular and Molecular Medicine, Infectious Diseases, St George's Hospital Medical School, Tooting, London, UK.

Postgraduate Medical Journal
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Frontiers of Drug Development Through the Use of New Approach Methodologies.

The AAPS journal·2026
Same author

Wearables and sleep apnoea.

British dental journal·2024
Same author

Leveraging AI and CRM integration for predictive oral health care.

British dental journal·2024
Same author

Corrigendum to "Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021" [IJID Regions Vol 1(2021) pages 107-116].

IJID regions·2024
Same author

Impact of variant subtype on electro-clinical phenotype of Dravet syndrome- a South Indian cohort study.

Seizure·2024
Same author

Framing future trajectories of human activities in the German North Sea to inform cumulative effects assessments and marine spatial planning.

Journal of environmental management·2023
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Artemisinins are potent antimalarial drugs offering rapid treatment and a wide therapeutic index. They are crucial for combating multidrug-resistant malaria and are being evaluated for severe cases.

Area of Science:

  • Pharmacology
  • Tropical Medicine
  • Infectious Diseases

Background:

  • Artemisinins, derived from artemisinin isolated in 1971, are highly effective antimalarial agents.
  • These compounds exhibit potent, rapid action against malaria parasites.
  • A key advantage is their wide therapeutic index and lack of significant clinical resistance.

Purpose of the Study:

  • To highlight the efficacy of artemisinin-containing regimens for multidrug-resistant malaria.
  • To discuss the ongoing comparative trials of artesunate versus quinine for severe malaria.
  • To assess the potential of these treatments in reducing high mortality rates associated with severe malaria.

Main Methods:

  • Review of artemisinin discovery and properties.
  • Analysis of artemisinin-containing regimens for drug-resistant malaria.

Related Experiment Videos

  • Inclusion of ongoing comparative trials for severe malaria treatment.

    • Main Results:

    • Artemisinins demonstrate potent and rapid antimalarial activity.
    • These drugs are effective against multidrug-resistant malaria strains.
    • Comparative trials are underway to evaluate artesunate and quinine for severe malaria.

    Conclusions:

    • Artemisinin-based therapies are vital for treating multidrug-resistant malaria.
    • Widespread deployment of artemisinin regimens is being advocated.
    • Further research through comparative trials aims to reduce mortality in severe malaria cases.